Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis.
Saki TakahashiYasuhiro TsujiNick H G HolfordChika OgamiHidefumi KasaiHitoshi KawasujiHideto ToYoshihiro YamamotoPublished in: European journal of drug metabolism and pharmacokinetics (2023)
This population pharmacokinetics model for unbound daptomycin could help clinicians to select the appropriate dose regimen for patients undergoing daptomycin treatment and reduce associated adverse effects.